PLOS ONE 2016 Apr 27;11(4):e0153163
The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study
Impact Factor 4.4
NATURE COMMUNICATIONS 2015 Jun 12;6:7208
Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels
Impact Factor 11.3
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 2015 Apr;44(2):578-86
Adiposity as a Cause of Cardiovascular Disease: A Mendelian Randomization Study in up to 50,117 Individuals
Impact Factor 7.5
DIABETES 2015 Volume 64 Issue 5: 1841-1852
Age- and Sex-specific causal Effects of Adiposity on cardiovascular Risk Factors
Impact Factor 8.5
ANTICANCER RESEARCH 2006 26: 1719-1726
Changes in the Circulating Plasma Levels of VEGF and VEGF-D after Adjuvant Chemotherapy in Patients with Breast Cancer and 1 to 3 Positive Lymph Nodes
Impact Factor 1.5
INTERNATIONAL JOURNAL OF CANCER 2006 119: 2885–2894
The thymidylate synthase tandem repeat promoter polymorphism: A predictor for
tumor-related survival in neoadjuvant treated locally advanced gastric cancer
Impact Factor 4.7